2024-04-01 2025-03-31 false No description of principal activity Capium Accounts Production 1.1 09131315 2024-04-01 2025-03-31 09131315 bus:AbridgedAccounts 2024-04-01 2025-03-31 09131315 bus:Micro-entities 2024-04-01 2025-03-31 09131315 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 09131315 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 09131315 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09131315 2024-04-01 2025-03-31 09131315 2025-03-31 09131315 bus:RegisteredOffice 2024-04-01 2025-03-31 09131315 core:WithinOneYear 2025-03-31 09131315 core:AfterOneYear 2025-03-31 09131315 1 2024-04-01 2025-03-31 09131315 bus:Director1 2024-04-01 2025-03-31 09131315 bus:Director1 2025-03-31 09131315 bus:Director1 2023-04-01 2024-03-31 09131315 bus:Director2 2024-04-01 2025-03-31 09131315 bus:Director2 2025-03-31 09131315 bus:Director2 2023-04-01 2024-03-31 09131315 2023-04-01 09131315 bus:CompanySecretary1 2024-04-01 2025-03-31 09131315 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 09131315 2023-04-01 2024-03-31 09131315 2024-03-31 09131315 core:WithinOneYear 2024-03-31 09131315 core:AfterOneYear 2024-03-31 09131315 bus:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 09131315 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass1 2025-03-31 09131315 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 09131315 bus:OrdinaryShareClass1 2024-03-31 09131315 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass2 2025-03-31 09131315 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 09131315 bus:OrdinaryShareClass2 2024-03-31 09131315 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass3 2025-03-31 09131315 bus:OrdinaryShareClass3 2023-04-01 2024-03-31 09131315 bus:OrdinaryShareClass3 2024-03-31 09131315 bus:OrdinaryShareClass4 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass4 2025-03-31 09131315 bus:OrdinaryShareClass4 2023-04-01 2024-03-31 09131315 bus:OrdinaryShareClass4 2024-03-31 09131315 bus:OrdinaryShareClass5 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass5 2025-03-31 09131315 bus:OrdinaryShareClass5 2023-04-01 2024-03-31 09131315 bus:OrdinaryShareClass5 2024-03-31 09131315 bus:OrdinaryShareClass6 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass6 2025-03-31 09131315 bus:OrdinaryShareClass6 2023-04-01 2024-03-31 09131315 bus:OrdinaryShareClass6 2024-03-31 09131315 bus:OrdinaryShareClass7 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass7 2025-03-31 09131315 bus:OrdinaryShareClass7 2023-04-01 2024-03-31 09131315 bus:OrdinaryShareClass7 2024-03-31 09131315 bus:OrdinaryShareClass8 2024-04-01 2025-03-31 09131315 bus:OrdinaryShareClass8 2025-03-31 09131315 bus:OrdinaryShareClass8 2023-04-01 2024-03-31 09131315 bus:OrdinaryShareClass8 2024-03-31 09131315 core:FurnitureFittings 2024-04-01 2025-03-31 09131315 core:FurnitureFittings 2025-03-31 09131315 core:FurnitureFittings 2024-03-31 09131315 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 09131315 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 09131315 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 09131315 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 09131315 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 09131315 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 09131315 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 09131315 core:Non-currentFinancialInstruments 2025-03-31 09131315 core:Non-currentFinancialInstruments 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 09131315
England and Wales

 

 

 

MS ENDOSCOPY LTD



Abridged Accounts
 


Period of accounts

Start date: 01 April 2024

End date: 31 March 2025
  2025   2024
    £ £   £ £
Fixed assets   2,540      2,013 
Current assets 120,872      101,823   
Creditors: amount falling due within one year (122,855)     (103,343)  
Net current assets   (1,983)     (1,520)
Total assets less current liabilities   557      493 
Provisions for liabilities   (537)     (473)
Net assets   20      20 
 

         
Capital and reserves   20      20 
 
NOTES TO THE ACCOUNTS

General Information
MS Endoscopy Ltd is a private company, limited by shares, registered in England and Wales, registration number 09131315, registration address 19 The Bramblings, Castleford, West Yorkshire, WF10 5ER.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees


Average number of employees during the year was 2 (2024 : 2).

3.

Director’s loan

Directors Loan Account

At 31st March 2025, the Directors Loan Account of £24,794 (2024 £10,088) is unsecured, repayable on demand and currently interest free. During the period the directors incurred the following transactions:


Director's Loan Account   Balance b/fwd
£
  Advances
£
  Credit
£
  Balance c/fwd
£
Director (10,088) 46,219  (60,925) (24,794)


For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the board of directors on 29 April 2025 and were signed on its behalf by:


--------------------------------
M B S Shetty
Director
1